Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Chronic Thrombocytopenia in Children: What Could It Hide?

Sara Mohamed, MD, Martina Di Palma, MD, Michela Faleschini, Daniela De Benedittis, MD, Maria Luisa Moleti, MD, Luisa Cardarelli, MD, Anna Maria Testi, MD, Giovanna Palumbo, MD, Anna Savoia, Fiorina Giona, MD

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-138651

Published: 2020

Journal Articles

Role of Blinatumomab in Minimal Residual Disease and Hematologic Relapsed/Refractory Adult Acute Lymphoblastic Leukemia Patients Treated over 5 Years. a Single Center Experience

Michela Ansuinelli, MD, Antonella Vitale, MD, Giovanna Pecoraro, MD, Saveria Capria, MD, Silvia Maria Trisolini, MD, Clara Minotti, MD, Claudio Cartoni, MD, Anna Maria Testi, MD, Maria Luisa Moleti, MD, Anna Paola Iori, MD, Walter Barberi, MD PhD, Irene Della Starza, PhD, Loredana Elia, Bs, Francesca Mancini, Maria Stefania De Propris, Anna Guarini, PhD, Sabina Chiaretti, MD PhD, Robin Foà, MD

Blood (2019) 134 (Supplement_1): 5121.

https://doi.org/10.1182/blood-2019-128156

Published: 2019

Journal Articles

Specific Guidelines Including Multidisciplinary Approach Is Critical of Management of Langerhans Cell Histiocytosis in Adults

Lorenzo Rizzo, Michelina Santopietro, MD, Gianluca Sfaciotti, MD, Marco Brunori, MD, Luisa Cardarelli, MD, Giovanna Palumbo, MD, Daniela De Benedittis, MD, Martina Di Palma, Maria Luisa Moleti, MD, Anna Maria Testi, MD, Tiziana Di Pippo, Fiorina Giona, MD

Blood (2019) 134 (Supplement_1): 1041.

https://doi.org/10.1182/blood-2019-129707

Published: 2019

Journal Articles

Prognostic Impact of t(4;11)(q21;q23)/ KMT2A-AFF1 -Positivity in 926 BCR-ABL1 -Negative B-Lineage Acute Lymphoblastic Leukemia Patients Treated in Gimema Clinical Trials Since 1996

Alfonso Piciocchi, Monica Messina, Loredana Elia, Bs, Antonella Vitale, MD, Stefano Soddu, Anna Maria Testi, MD, Sabina Chiaretti, MD PhD, Marco Mancini, MD, Giorgina Specchia, MD, Antonio Spadano, MD, Mauro Krampera, Roberto Cairoli, MD, Francesco Di Raimondo, MD, Felicetto Ferrara, MD, Giuseppe Cimino, MD, Renato Bassan, MD, Paola Fazi, MD, Marco Vignetti, MD

Blood (2019) 134 (Supplement_1): 1469.

https://doi.org/10.1182/blood-2019-121977

Published: 2019

Journal Articles

Next-Generation Sequencing (NGS) in Childhood Myeloproliferative Diseases (MPD)

Michelina Santopietro, MD, Giovanna Palumbo, MD, Maria Luisa Moleti, MD, Anna Maria Testi, MD, Luisa Cardarelli, MD, Nicola Monaco, MDcal Student, Francesco Malaspina, MD, Camilla Presicce, MDcal Student, Sonia Maria Orlando, Alessandro Pancrazzi, PhD, Annalisa Pacilli, PhD, Giada Rotunno, PhD, Alessandro M. Vannucchi, MD, Robin Foà, MD, Fiorina Giona, MD

Blood (2018) 132 (Supplement 1): 3049.

https://doi.org/10.1182/blood-2018-99-118102

Published: 2018

Journal Articles

Intermittent Imatinib Mesylate in Children with Chronic Myeloid Leukemia: Results and Outcome

Francesco Malaspina, MD, Maria Caterina Putti, MD, Michelina Santopietro, MD, Saverio Ladogana, MD, Rosamaria Mura, MD, Roberta Burnelli, MD, Nadia Vacca, MD, Lorenzo Rizzo, Maria Luisa Moleti, MD, Anna Maria Testi, MD, Andrea Biondi, Franco Locatelli, Giuseppe Saglio, Robin Foà, MD, Fiorina Giona, MD

Blood (2018) 132 (Supplement 1): 4256.

https://doi.org/10.1182/blood-2018-99-118030

Published: 2018

Journal Articles

Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL

Anna Maria Testi, Andrea Pession, Daniela Diverio, David Grimwade, Brenda Gibson, Amilcar Cardoso de Azevedo, Lorena Moran, Guy Leverger, Sarah Elitzur, Henrik Hasle, Jutte van der Werff ten Bosch, Owen Smith, Marisa De Rosa, Alfonso Piciocchi, Francesco Lo Coco, Robin Foà, Franco Locatelli, Gertjan J. L. Kaspers

Blood (2018) 132 (4): 405–412.

https://doi.org/10.1182/blood-2018-03-836528

Published: 2018

Includes: Supplemental data

Journal Articles

Clinical Characteristics and Treatment Outcome of Acute Myeloid Leukemia with APL-like Morphology and Uncommon RARA Fusion Variants

Oussama Abla, MD, Laura Cicconi, Pau Montesinos, MD PhD, Eduardo Magalhães Rego, MDPhD, Anthony P Schwarer, MD MBBS (Hons), FRACP, FRCPA, Elihu H. Estey, MD, Anna Maria Testi, MD, Jordi Esteve, MD, Ombretta Annibali, Alessandra Scardocci, MD, Roberto Castelli, MD, Vladimir Lazarevic, MD PhD, Franco Locatelli, MD PhD, Jeevan Kumar, MD, Miguel A. Sanz, MD, Francesco Lo Coco, MD

Blood (2017) 130 (Supplement 1): 3860.

https://doi.org/10.1182/blood.V130.Suppl_1.3860.3860

Published: 2017

Journal Articles

Risk-Group Stratified and Minimal Residual Disease (MRD)-Guided Treatment with Extended ATRA and Reduced-Anthracycline Chemotherapy in Childhood Acute Promyelocytic Leukemia (APL): Results from ICC APL Study 01 (NCT01226303; EudraCT 2008-002311-40)

Anna Maria Testi, MD, Andrea Pession, MD, David Grimwade, PhD FRCPath, Daniela Diverio, PhD, Christine Ragu, PhD, Sarah Elitzur, MD, Alcira Fynn, MD, Henrik Hasle, MD PhD, Jutte Van der Werff ten Bosch, MD PhD, Owen Smith, MD, Brenda Gibson, MD, Franco Locatelli, MD PhD, Gertjan J.L. Kaspers, MD PhD

Blood (2015) 126 (23): 563.

https://doi.org/10.1182/blood.V126.23.563.563

Published: 2015

Journal Articles

Predictors of Early Death in Childhood Acute Promyelocytic Leukemia: Results of an International Retrospective Study

Oussama Abla, MD, Raul C. Ribeiro, MD, Anna Maria Testi, MD, Pau Montesinos Fernández, MD, Ursula Creutzig, MD, Lillian Sung, MD PhD, Giancarlo Di Giuseppe, BSc, Derek Stephens, MSc, Henrik Hasle, MD PhD, Gertjan J.L. Kaspers, MD PhD, Luciano Dalla-Pozza, MB BS FRACP, Alvaro Lassaletta, MD, Martin S. Tallman, MD, Franco Locatelli, MD, Dirk Reinhardt, MD, Johann Hitzler, MD FRCP (C), FAAP, Miguel A. Sanz, MD PhD

Blood (2015) 126 (23): 172.

https://doi.org/10.1182/blood.V126.23.172.172

Published: 2015

Journal Articles

Independent Prognostic Impact of CD15 for Achievement of Complete Remission in Patients with Acute Myeloid Leukemia

Blood (2014) 124 (21): 3687.

https://doi.org/10.1182/blood.V124.21.3687.3687

Published: 2014

Journal Articles

Outcome of Early T-Cell Precursor Acute Lymphoblastic Leukemia in AIEOP Patients Treated with the AIEOP-BFM ALL 2000 Study

Blood (2014) 124 (21): 3780.

https://doi.org/10.1182/blood.V124.21.3780.3780

Published: 2014

Journal Articles

Acute Myeloid Leukemia Patients with an Undefined Genetic Profile at Diagnosis: Clinical and Prognostic Aspects

Blood (2014) 124 (21): 5326.

https://doi.org/10.1182/blood.V124.21.5326.5326

Published: 2014

Journal Articles

Role of CD133 As a Marker of Previous Myelodysplasia in De Novo Elderly Patients with Acute Myeloid Leukemia

Blood (2014) 124 (21): 1063.

https://doi.org/10.1182/blood.V124.21.1063.1063

Published: 2014

Journal Articles

CRLF2 over-Expression Is a Poor Prognostic Marker in Children with High Risk T-Cell Acute Lymphoblastic Leukemia

Blood (2014) 124 (21): 1071.

https://doi.org/10.1182/blood.V124.21.1071.1071

Published: 2014

Journal Articles

FLT3-ITD As a Target for Minimal Residual Disease Monitoring in Early T-Cell Precursor (ETP) Acute Lymphoblastic Leukemia

Nellina Andriano, Barbara Buldini, Daniela Silvestri, Tiziana Villa, Franco Locatelli, Rosanna Parasole, Elena Barisone, Anna Maria Testi, Andrea Biondi, Maria Grazia Valsecchi, Valentino Conter, Giuseppe Basso, Luca Lo Nigro, Giovanni Cazzaniga

Blood (2014) 124 (21): 1073.

https://doi.org/10.1182/blood.V124.21.1073.1073

Published: 2014

Journal Articles

Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study

Blood (2014) 123 (10): 1470–1478.

https://doi.org/10.1182/blood-2013-10-532598

Published: 2014

Includes: Supplemental data

Journal Articles

Can Children and Adolescents With Chronic Myelogenous Leukemia Be Cured Without Stem Cell Transplant? A Single Center Experience

Fiorina Giona, Benedetta Siniscalchi, Maria Luisa Moleti, Massimiliano Rea, Deborah Marzella, Mauro Nanni, Enrico Gottardi, Anna Paola Iori, Daniela Diverio, Anna Maria Testi, Giuseppe Saglio, MD, Robin Foa'

Blood (2013) 122 (21): 4033.

https://doi.org/10.1182/blood.V122.21.4033.4033

Published: 2013

Journal Articles

Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia

Andrea Pession, Riccardo Masetti, Carmelo Rizzari, Maria Caterina Putti, Fiorina Casale, Franca Fagioli, Matteo Luciani, Luca Lo Nigro, Giuseppe Menna, Concetta Micalizzi, Nicola Santoro, Anna Maria Testi, Marco Zecca, Andrea Biondi, Martina Pigazzi, Sergio Rutella, Roberto Rondelli, Giuseppe Basso, Franco Locatelli

Blood (2013) 122 (2): 170–178.

https://doi.org/10.1182/blood-2013-03-491621

Published: 2013

Journal Articles

Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome

Fiorina Giona, Luciana Teofili, Maria Luisa Moleti, Maurizio Martini, Giovanna Palumbo, Angela Amendola, Maria Gabriella Mazzucconi, Anna Maria Testi, Patrizia Pignoloni, Sonia Maria Orlando, Sara Capodimonti, Mauro Nanni, Giuseppe Leone, Luigi Maria Larocca, Robin Foà

Blood (2012) 119 (10): 2219–2227.

https://doi.org/10.1182/blood-2011-08-371328

Published: 2012

Includes: Supplemental data

NARROW

Chronic Thrombocytopenia in Children: What Could It Hide?

Role of Blinatumomab in Minimal Residual Disease and Hematologic Relapsed/Refractory Adult Acute Lymphoblastic Leukemia Patients Treated over 5 Years. a Single Center Experience

Specific Guidelines Including Multidisciplinary Approach Is Critical of Management of Langerhans Cell Histiocytosis in Adults

Prognostic Impact of t(4;11)(q21;q23)/ KMT2A-AFF1 -Positivity in 926 BCR-ABL1 -Negative B-Lineage Acute Lymphoblastic Leukemia Patients Treated in Gimema Clinical Trials Since 1996

Next-Generation Sequencing (NGS) in Childhood Myeloproliferative Diseases (MPD)

Intermittent Imatinib Mesylate in Children with Chronic Myeloid Leukemia: Results and Outcome

Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL

Clinical Characteristics and Treatment Outcome of Acute Myeloid Leukemia with APL-like Morphology and Uncommon RARA Fusion Variants

Risk-Group Stratified and Minimal Residual Disease (MRD)-Guided Treatment with Extended ATRA and Reduced-Anthracycline Chemotherapy in Childhood Acute Promyelocytic Leukemia (APL): Results from ICC APL Study 01 (NCT01226303; EudraCT 2008-002311-40)

Predictors of Early Death in Childhood Acute Promyelocytic Leukemia: Results of an International Retrospective Study

Independent Prognostic Impact of CD15 for Achievement of Complete Remission in Patients with Acute Myeloid Leukemia

Outcome of Early T-Cell Precursor Acute Lymphoblastic Leukemia in AIEOP Patients Treated with the AIEOP-BFM ALL 2000 Study

Acute Myeloid Leukemia Patients with an Undefined Genetic Profile at Diagnosis: Clinical and Prognostic Aspects

Role of CD133 As a Marker of Previous Myelodysplasia in De Novo Elderly Patients with Acute Myeloid Leukemia

CRLF2 over-Expression Is a Poor Prognostic Marker in Children with High Risk T-Cell Acute Lymphoblastic Leukemia

FLT3-ITD As a Target for Minimal Residual Disease Monitoring in Early T-Cell Precursor (ETP) Acute Lymphoblastic Leukemia

Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study

Can Children and Adolescents With Chronic Myelogenous Leukemia Be Cured Without Stem Cell Transplant? A Single Center Experience

Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia

Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only